tm logo
Trademark Search
GENIA

View On IC.GC.CA

GENIA
REGISTERED

on 04 Jan 2023

Last Applicant/ Owned by

ROCHE DIAGNOSTICS GMBH

Sandhofer Strasse 11668305 Mannheim

DE

Serial Number

2051998 filed on 23rd Mar 2020

Registration Number

TMA1159122 registered on 04th Jan 2023

Registration expiry Date

23rd Mar 2030

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

GENIA

Trademark usage description

in vitro diagnostic devices and instruments, namely pcr thermal cyclers, dna microarrays, genetic analyzers for identifying, analyzing, measuring and Read More

Classification Information

Class [009]
In vitro diagnostic devices and instruments, namely PCR thermal cyclers, DNA microarrays, genetic analyzers for identifying, analyzing, measuring and recording human DNA molecules for use in scientific research and clinical laboratory research use; laboratory devices, namely PCR thermal cyclers, DNA microarrays, genetic analyzers for the detection of genomes, DNA, pathogens and toxins in a human biological sample for scientific research and for clinical laboratory research use; In vitro diagnostic devices and instruments, namely PCR thermal cyclers, DNA microarrays, genetic analyzers for identifying, analyzing, measuring, sequencing, and recording human antigen and antibody molecules for use in scientific research and clinical laboratory research use; laboratory instruments, namely PCR thermal cyclers, DNA microarrays, genetic analyzers for analyzing nucleic acids and for DNA sequencing for scientific research and for clinical laboratory research use; nucleic acid sequencers; genotyping and gene expression microarrays, associated mapping files and associated kits for analyzing nucleic acids for scientific, pharmaceutical and medical research purposes; software for use in analyzing, managing and visualizing DNA sequencing data for use in the fields of scientific research, clinical diagnostic and research, and clinical laboratory diagnostic purposes, namely, in vitro diagnostic software as a medical device to enable scientists, physicians, patients, hospitals, and medical clinics to monitor patient treatment progress, to operate artificial intelligence automation, to rapidly connect the dots between patient symptoms, healthcare professional diagnosis, and evidence-based research in the field of biomarkers and disease indicators, clinical chemistry and immunoassays, molecular diagnostics, molecular sequencing; computer software for laboratory automation to support medical diagnosis in the field of scientific research, pharmaceutical research and medical research, laboratory workflow and in vitro diagnostic information for use in the fields of scientific research, clinical diagnostic and research, and clinical laboratory diagnostic purposes; software for use in analyzing, managing and visualizing DNA sequencing data.

Classification kind code

11

Class [010]
Medical diagnostic instruments namely polymerase chain reaction amplifier for use in medical and clinical laboratory use; medical devices and instruments, namely PCR thermal cyclers, DNA microarrays, genetic analyzers for identifying, analyzing, measuring and recording human DNA molecules for medical and clinical laboratory use; medical devices and instruments, namely PCR thermal cyclers, DNA microarrays, genetic analyzers for identifying, analyzing, measuring, sequencing, and recording human biomolecules for medical and clinical laboratory use; medical equipment, namely PCR thermal cyclers, DNA microarrays, genetic analyzers for analyzing nucleic acids and for DNA sequencing for the purpose of rendering medical treatment and diagnosis in medical and clinical and laboratory use.

Classification kind code

11

Class [042]
Scientific research in the field of genetics and genetic engineering; scientific consultancy and research related thereto in the fields of genome sequence analysis and reporting; medical research services; providing DNA screening for scientific research purposes; providing DNA screening for scientific research purposes; providing laboratory diagnostic research services for others in the fields of human tissue diagnostics, liquid biopsy, and genome and DNA sequencing; consulting services in the field of cloud computing providing software for database management in the fields of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of life science; computer services, namely cloud hosting provider services for storing, analyzing and sharing data in the fields of life science; providing online nondownloadable software for the custom design and ordering of assays and reagents; design and development of laboratory apparatus and instruments and computer systems for use in science and clinical research; providing consultancy, information and advisory services in the field of analysis of biomolecules.

Classification kind code

11

Class [044]
Medical services for analysis of genetics namely genetic testing for medical purposes; genetic diagnostics for medical purposes; nucleic acid based testing for medical purposes; medical services in the field of nucleic acid analysis; medical services in the field of genetic screening.

Classification kind code

11

Mark Details

Serial Number

2051998

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 15th Nov 2021		Search Recorded
Submitted for opposition 256
on 19th Jul 2021		Notification of Possible Opposition Sent
Submitted for opposition 48
on 19th Apr 2021		Agent Changed
Submitted for opposition 257
on 31st Dec 2020		Designation Notification - Madrid Protocol
Submitted for opposition 257
on 17th Sep 2020		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 16th Sep 2020		Created
Submitted for opposition 31
on 16th Sep 2020		Formalized
Submitted for opposition 30
on 23rd Mar 2020		Filed
Submitted for opposition 228
on 23rd Mar 2020		International Registration
Submitted for opposition 210
on 23rd Mar 2020		IR Correction